HPV9 vaccine, or Gardasil 9, to be added to national immunisation schedules from January 2027

The HPV9 vaccine, which offers broader protection against cervical cancer than HPV2, will be fully subsidised for eligible Singaporean children.

A box of Gardasil 9 human papillomavirus virus (HPV) vaccine. (File photo: AFP/Patrick T Fallon)

This audio is generated by an AI tool.

SINGAPORE: Gardasil 9, a human papillomavirus (HPV) vaccine that offers broader protection against cervical cancer, will be added to Singapore's national immunisation schedules from Jan 1, 2027.

The HPV 9-valent vaccine, or HPV9, will be included in the National Childhood Immunisation Schedule (NCIS) and National Adult Immunisation Schedule (NAIS) for females aged nine to 26, the Ministry of Health (MOH), Health Promotion Board (HPB) and Communicable Diseases Agency (CDA) said on Friday (Oct 2).

It will also be added to the Subsidised Vaccine List, making government subsidies available for eligible Singaporeans and permanent residents.

“The HPV2 vaccine, also known as Cervarix, will remain on both schedules as an alternative option,” the authorities said.

CNA Games Guess Word Crack the word, one row at a time Buzzword Create words using the given letters Mini Sudoku Tiny puzzle, mighty brain teaser Mini Crossword Small grid, big challenge Word Search Spot as many words as you can Show More Show Less Currently, government subsidies and MediSave cannot be used for HPV9 vaccination. At Singapore Women's Clinic, for example, HPV9 currently costs S$250 (US$195) per dose, more than twice the S$96 charged for the HPV2 vaccine, or Cervarix, according to the clinic's website. From Jan 1, eligible Singaporean children will receive full subsidies for HPV9 at CHAS GP clinics and polyclinics. Eligible Singaporean adults can receive means-tested subsidies of up to 75 per cent at these clinics, while eligible permanent residents can receive subsidies at polyclinics. MediSave use will also be extended to HPV9 for those in the recommended groups, subject to the prevailing MediSave Chronic and Preventive Care withdrawal limits. Vaccination subsidies and MediSave use will not be applicable to additional doses of the HPV9 vaccine for those who have already completed the recommended doses. BROADER PROTECTION AGAINST CERVICAL CANCER HPV vaccination is recommended in Singapore for females aged nine to 26 to prevent cervical cancer. Both HPV2 and HPV9 protect against HPV types 16 and 18, which cause 70 per cent of all cervical cancers. HPV9 also protects against additional HPV types that account for a further 20 per cent of cervical cancers, bringing its coverage to about 90 per cent, the authorities said. Human papillomavirus is a common sexually transmitted infection. It can cause cervical cancer as well as cancers of the anus, throat, vulva, vagina and penis. HPV9 is registered for use in both females and males in Singapore, while HPV2 is registered for females.

Currently, government subsidies and MediSave cannot be used for HPV9 vaccination.

At Singapore Women's Clinic, for example, HPV9 currently costs S$250 (US$195) per dose, more than twice the S$96 charged for the HPV2 vaccine, or Cervarix, according to the clinic's website.

From Jan 1, eligible Singaporean children will receive full subsidies for HPV9 at CHAS GP clinics and polyclinics.

Eligible Singaporean adults can receive means-tested subsidies of up to 75 per cent at these clinics, while eligible permanent residents can receive subsidies at polyclinics.

MediSave use will also be extended to HPV9 for those in the recommended groups, subject to the prevailing MediSave Chronic and Preventive Care withdrawal limits.

Vaccination subsidies and MediSave use will not be applicable to additional doses of the HPV9 vaccine for those who have already completed the recommended doses.

BROADER PROTECTION AGAINST CERVICAL CANCER

HPV vaccination is recommended in Singapore for females aged nine to 26 to prevent cervical cancer.

Both HPV2 and HPV9 protect against HPV types 16 and 18, which cause 70 per cent of all cervical cancers.

HPV9 also protects against additional HPV types that account for a further 20 per cent of cervical cancers, bringing its coverage to about 90 per cent, the authorities said.

Human papillomavirus is a common sexually transmitted infection. It can cause cervical cancer as well as cancers of the anus, throat, vulva, vagina and penis.

HPV9 is registered for use in both females and males in Singapore, while HPV2 is registered for females.

HPV9 REPLACES HPV2 IN SCHOOLS

Gardasil 9 will also replace HPV2 under HPB's school-based HPV vaccination programme from Jan 1.

Under the programme, HPV vaccinations are offered at no charge to Secondary 1 and 2 female students.

Female students who have yet to start or complete their vaccination series will receive HPV9.

Those in the 2026 Secondary 1 cohort who received HPV2 as their first dose will receive HPV9 as their second dose in school in 2027.

Students who have already completed their recommended HPV vaccination series will not receive additional HPV9 doses under the school programme.

Get our pick of top stories and thought-provoking articles in your inbox

Stay updated with notifications for breaking news and our best stories

Join our channel for the top reads for the day on your preferred chat app

HPV9疫苗比HPV2疫苗能更广泛地预防宫颈癌，符合条件的新加坡儿童将获得全额补贴。

一盒加卫苗9价人乳头瘤病毒（HPV）疫苗。（资料照片：法新社/帕特里克·T·法伦）

这段音频由人工智能工具生成。

新加坡：从 2027 年 1 月 1 日起，新加坡将把 Gardasil 9（一种能更广泛地预防宫颈癌的人乳头瘤病毒 (HPV) 疫苗）纳入国家免疫计划。

卫生部、健康促进局和传染病机构于周五（10 月 2 日）宣布，HPV 9 价疫苗（HPV9）将被纳入国家儿童免疫计划（NCIS）和国家成人免疫计划（NAIS），适用于 9 至 26 岁的女性。

该疫苗还将列入政府补贴疫苗清单，符合条件的新加坡公民和永久居民可享受政府补贴。

当局表示：“HPV2疫苗，也称为Cervarix，将继续作为替代方案保留在两个接种计划中。”

CNA游戏 猜词游戏 逐行破解单词 流行词游戏 用给定的字母组成单词 迷你数独 小谜题，脑力挑战 迷你填字游戏 小方格，大挑战 单词搜索 尽可能多地找出单词 显示更多 显示更少 目前，政府补贴和保健储蓄账户（MediSave）不能用于HPV9疫苗接种。例如，根据新加坡妇女诊所的网站信息，HPV9疫苗目前每剂收费250新元（195美元），是HPV2疫苗（Cervarix）96新元的两倍多。从1月1日起，符合条件的新加坡儿童将在CHAS全科医生诊所和综合诊所获得HPV9疫苗的全额补贴。符合条件的新加坡成年人可以在这些诊所获得最高75%的补贴（需进行经济状况调查），而符合条件的永久居民可以在综合诊所获得补贴。保健储蓄账户（MediSave）的使用范围也将扩大到HPV9疫苗，适用于推荐人群，但需遵守现行的保健储蓄账户慢性病和预防保健提取限额。对于已完成推荐剂次HPV9疫苗接种的人士，疫苗补贴和保健储蓄账户（MediSave）的使用将不适用于额外剂次的HPV9疫苗。更广泛​​地预防宫颈癌：新加坡建议9至26岁的女性接种HPV疫苗以预防宫颈癌。HPV2和HPV9均可预防HPV 16型和18型病毒感染，这两种病毒感染导致70%的宫颈癌病例。当局表示，HPV9还可预防其他导致宫颈癌的HPV病毒类型（约占20%），使其覆盖率达到约90%。人乳头瘤病毒（HPV）是一种常见的性传播感染。它可导致宫颈癌以及肛门癌、咽喉癌、外阴癌、阴道癌和阴茎癌。HPV9已在新加坡注册用于男性和女性，而HPV2仅注册用于女性。

目前，政府补贴和保健储蓄不能用于接种HPV9疫苗。

例如，据新加坡妇女诊所网站显示，HPV9 疫苗目前每剂收费 250 新元（195 美元），是 HPV2 疫苗（Cervarix）每剂收费 96 新元的两倍多。

从 1 月 1 日起，符合条件的新加坡儿童将在 CHAS 全科医生诊所和综合诊所获得 HPV9 全额补贴。

符合资格的新加坡成年人可以在这些诊所获得高达 75% 的经济状况调查补贴，而符合资格的永久居民可以在综合诊所获得补贴。

医疗储蓄计划的使用范围也将扩大到推荐人群的 HPV9 疫苗，但须遵守现行的医疗储蓄计划慢性病和预防保健提取限额。

对于已经完成推荐剂次HPV9疫苗接种的人，疫苗补贴和保健储蓄金将不适用于额外剂次的HPV9疫苗接种。

更广泛地预防宫颈癌

新加坡建议9至26岁的女性接种HPV疫苗，以预防宫颈癌。

HPV2 和 HPV9 都能预防 HPV 16 型和 18 型感染，这两种病毒会导致 70% 的宫颈癌。

当局表示，HPV9 还可以预防其他导致宫颈癌的 HPV 类型（占宫颈癌病例的 20%），使其覆盖率达到约 90%。

人乳头瘤病毒是一种常见的性传播感染。它可导致宫颈癌以及肛门癌、咽喉癌、外阴癌、阴道癌和阴茎癌。

HPV9 在新加坡已注册用于男性和女性，而 HPV2 仅注册用于女性。

HPV9 取代 HPV2 在学校进行疫苗接种

从 1 月 1 日起，Gardasil 9 也将取代 HPV2，纳入新加坡卫生促进局 (HPB) 的学校 HPV 疫苗接种计划。

根据该计划，中学一年级和二年级的女生可免费接种HPV疫苗。

尚未开始或完成疫苗接种程序的女学生将接种 HPV9 疫苗。

2026 年就读中学一年级的学生，如果第一剂接种的是 HPV2 疫苗，那么他们将在 2027 年在学校接种第二剂 HPV9 疫苗。

已完成推荐的HPV疫苗接种系列的学生将不会根据学校计划接受额外的HPV9疫苗接种。

订阅我们的邮件，即可获取精选热点新闻和引人深思的文章。

订阅通知，第一时间获取突发新闻和精彩报道。

加入我们的频道，即可在您常用的聊天应用上获取当日热门文章。